1. Home
  2. SGHT vs GEVO Comparison

SGHT vs GEVO Comparison

Compare SGHT & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$5.48

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Logo Gevo Inc.

GEVO

Gevo Inc.

HOLD

Current Price

$1.43

Market Cap

340.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
GEVO
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
340.8M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
SGHT
GEVO
Price
$5.48
$1.43
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$9.08
$6.58
AVG Volume (30 Days)
186.8K
3.6M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
58.82
EPS
N/A
N/A
Revenue
$77,363,000.00
$711,000.00
Revenue This Year
$11.67
$19.44
Revenue Next Year
$10.39
$5.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.11
$1.12
52 Week High
$9.24
$2.97

Technical Indicators

Market Signals
Indicator
SGHT
GEVO
Relative Strength Index (RSI) 59.95 39.30
Support Level $4.76 $1.37
Resistance Level $5.66 $1.57
Average True Range (ATR) 0.36 0.09
MACD 0.01 0.01
Stochastic Oscillator 65.20 25.64

Price Performance

Historical Comparison
SGHT
GEVO

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About GEVO Gevo Inc.

Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

Share on Social Networks: